文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

食管癌和胃癌的人群归因风险。

Population attributable risks of esophageal and gastric cancers.

作者信息

Engel Lawrence S, Chow Wong-Ho, Vaughan Thomas L, Gammon Marilie D, Risch Harvey A, Stanford Janet L, Schoenberg Janet B, Mayne Susan T, Dubrow Robert, Rotterdam Heidrun, West A Brian, Blaser Martin, Blot William J, Gail Mitchell H, Fraumeni Joseph F

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

出版信息

J Natl Cancer Inst. 2003 Sep 17;95(18):1404-13. doi: 10.1093/jnci/djg047.


DOI:10.1093/jnci/djg047
PMID:13130116
Abstract

BACKGROUND: Several risk factors have been identified for esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and noncardia gastric adenocarcinoma, but no study has comprehensively examined their contributions to the cancer burden in the general population. Herein, we estimate the population attributable risks (PARs) for various risk factors observed in a multicenter population-based case-control study. METHODS: We calculated PARs by using 293 patients with esophageal adenocarcinoma, 261 with gastric cardia adenocarcinoma, 221 with esophageal squamous cell carcinoma, 368 with noncardia gastric adenocarcinoma, and 695 control subjects. We included smoking for all four tumor types and Helicobacter pylori infection for noncardia gastric adenocarcinoma as established causal risk factors as well as several other factors for which causality is under evaluation. RESULTS: Ever smoking, body mass index above the lowest quartile, history of gastroesophageal reflux, and low fruit and vegetable consumption accounted for 39.7% (95% confidence interval [CI] = 25.6% to 55.8%), 41.1% (95% CI = 23.8% to 60.9%), 29.7% (95% CI = 19.5% to 42.3%), and 15.3% (95% CI = 5.8% to 34.6%) of esophageal adenocarcinomas, respectively, with a combined PAR of 78.7% (95% CI = 66.5% to 87.3%). Ever smoking and body mass index above the lowest quartile were responsible for 45.2% (95% CI = 31.3% to 59.9%) and 19.2% (95% CI = 4.9% to 52.0%) of gastric cardia adenocarcinomas, respectively, with a combined PAR of 56.2% (95% CI = 38.1% to 72.8%). Ever smoking, alcohol consumption, and low fruit and vegetable consumption accounted for 56.9% (95% CI = 36.6% to 75.1%), 72.4% (95% CI = 53.3% to 85.8%), and 28.7% (95% CI = 11.1% to 56.5%) of esophageal squamous cell carcinomas, respectively, with a combined PAR of 89.4% (95% CI = 79.1% to 95.0%). Ever smoking, history of gastric ulcers, nitrite intake above the lowest quartile, and H. pylori infection were responsible for 18.3% (95% CI = 6.5% to 41.8%), 9.7% (95% CI = 5.4% to 16.8%), 40.7% (95% CI = 23.4% to 60.7%), and 10.4% (95% CI = 0.3% to 79.6%) of noncardia gastric adenocarcinomas, respectively, with a combined PAR of 59.0% (95% CI = 16.2% to 91.4%). CONCLUSION: In this population, a few known risk factors account for a majority of esophageal and gastric cancers. These results suggest that the incidence of these cancers may be decreased by reducing the prevalence of smoking, gastroesophageal reflux, and being overweight and by increasing the consumption of fruits and vegetables.

摘要

背景:已确定了食管腺癌、贲门胃癌、食管鳞状细胞癌和非贲门胃癌的多种风险因素,但尚无研究全面考察它们对普通人群癌症负担的影响。在此,我们估计了在一项基于多中心人群的病例对照研究中观察到的各种风险因素的人群归因风险(PARs)。 方法:我们使用293例食管腺癌患者、261例贲门胃癌患者、221例食管鳞状细胞癌患者、368例非贲门胃癌患者和695例对照受试者计算PARs。我们将所有四种肿瘤类型的吸烟以及非贲门胃癌的幽门螺杆菌感染作为已确定的因果风险因素,以及其他一些因果关系正在评估的因素纳入研究。 结果:曾经吸烟、体重指数高于最低四分位数、胃食管反流病史以及水果和蔬菜摄入量低分别占食管腺癌的39.7%(95%置信区间[CI]=25.6%至55.8%)、41.1%(95%CI=23.8%至60.9%)、29.7%(95%CI=19.5%至42.3%)和15.3%(95%CI=5.8%至34.6%),合并PAR为78.7%(95%CI=66.5%至87.3%)。曾经吸烟和体重指数高于最低四分位数分别占贲门胃癌的45.2%(95%CI=31.3%至59.9%)和19.2%(95%CI=4.9%至52.0%),合并PAR为56.2%(95%CI=38.1%至72.8%)。曾经吸烟、饮酒以及水果和蔬菜摄入量低分别占食管鳞状细胞癌的56.9%(95%CI=36.6%至75.1%)、72.4%(95%CI=53.3%至85.8%)和28.7%(95%CI=11.1%至56.5%),合并PAR为89.4%(95%CI=79.1%至95.0%)。曾经吸烟、胃溃疡病史、亚硝酸盐摄入量高于最低四分位数以及幽门螺杆菌感染分别占非贲门胃癌的18.3%(95%CI=6.5%至41.8%)、9.7%(95%CI=5.4%至16.8%)、40.7%(95%CI=23.4%至60.7%)和10.4%(95%CI=0.3%至79.6%),合并PAR为59.0%(95%CI=16.2%至91.4%)。 结论:在该人群中,一些已知风险因素占食管和胃癌的大部分。这些结果表明,通过降低吸烟、胃食管反流和超重的患病率以及增加水果和蔬菜的摄入量,这些癌症的发病率可能会降低。

相似文献

[1]
Population attributable risks of esophageal and gastric cancers.

J Natl Cancer Inst. 2003-9-17

[2]
A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes.

Am J Epidemiol. 2007-6-15

[3]
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia.

J Natl Cancer Inst. 1997-9-3

[4]
Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden.

Nutr Cancer. 2006

[5]
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study.

Cancer Causes Control. 2005-4

[6]
Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).

J Natl Cancer Inst. 2006-3-1

[7]
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.

Cancer Causes Control. 2009-4

[8]
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.

J Natl Cancer Inst. 2004-3-3

[9]
A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States).

Cancer Causes Control. 2001-10

[10]
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.

J Natl Cancer Inst. 1998-1-21

引用本文的文献

[1]
Causal association between modifiable risk factors and esophageal cancer: A Mendelian randomization study.

Discov Oncol. 2025-7-14

[2]
Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data.

Sci Rep. 2025-7-1

[3]
Whole genome sequencing revealed esophageal squamous cell carcinoma related biomarkers.

PLoS One. 2025-6-26

[4]
Carcinoma of Esophagus.

J Gastroenterol Hepatol. 2025-8

[5]
Risk of serum circulating environmental chemical residues to esophageal squamous cell carcinoma: a nested case-control metabolome-wide association study.

Anal Bioanal Chem. 2025-5

[6]
Socioeconomic disparities and the genomic landscape of gastric cancer.

Sci Rep. 2024-7-2

[7]
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.

Cancer Immunol Immunother. 2024-6-4

[8]
Associations between "Cancer Risk", "Inflammation" and "Metabolic Syndrome": A Scoping Review.

Biology (Basel). 2024-5-16

[9]
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial.

J Clin Oncol. 2024-7-10

[10]
Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case-control study.

EClinicalMedicine. 2024-3-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索